Prothena Corp PLC (NAS:PRTA)
$ 20.11 -0.93 (-4.42%) Market Cap: 1.08 Bil Enterprise Value: 597.88 Mil PE Ratio: 0 PB Ratio: 2.15 GF Score: 66/100

Prothena Corporation PLC at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript

May 19, 2021 / 12:35PM GMT
Release Date Price: $23.97 (+0.59%)
Kennen MacKay
RBC Capital Markets,RBC Biotechnology Research - Managing Director

Hi, my name is Kennen MacKay, and I am pleased to kick off our next session with Prothena. From Prothena, we have Dr. Gene Kinney, the Chief Executive Officer as well as Tran Nguyen, the Chief Financial Officer. Gene, Tran, thanks so much for joining us this morning.

Gene Kinney
Prothena Corporation plc - President and CEO, Director

Well, thanks for having us, Kennen. Appreciate being here.

Tran Nguyen
Prothena Corporation plc - COO and CFO

Absolutely, thanks, Kennen.

Kennen MacKay
RBC Capital Markets,RBC Biotechnology Research - Managing Director

So I'd love to dive into the resurgence of not only amyloid but also Birtamimab and AL Amyloidosis. But before we jump in, just given the recent ADP meeting and the fact that yourselves and a huge portion of the team at Prothena are some of the world's experts on Alzheimer's, and maybe we can just start there. I'd love to hear your takeaways on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot